<p>/PRNewswire/ -- 前路易斯安那州检察长查尔斯·C·福提（Charles C. Foti, Jr.）及其法律事务所 Kahn Swick &amp; Foti, LLC（&#34;KSF&#34;）正在调查 Astria Therapeutics, Inc.（纳斯达克代码：ATXS）拟出售给 BioCryst Pharmaceuticals, Inc.（纳斯达克代码：BCRX）的交易。根据拟议交易的条款，Astria 的股东将为每持有一股 Astria 股票获得 8.55 美元现金和 0.59 股 BioCryst 普通股。KSF 正在寻求确定这一对价及其形成过程是否合理，或者该对价是否低估了公司。</p>
<p>如果您认为该交易低估了公司，和/或如果您希望讨论您关于拟议出售的法律权利，您可以随时通过电子邮件或拨打 855-768-1857（免费电话）联系 KSF 管理合伙人路易斯·S·卡恩（Lewis S. Kahn）（[email protected]），而无需承担任何义务或费用，或访问 https://www.ksfcounsel.com/cases/nasdaqgm-atxs/以了解更多信息。</p>
<p>要了解更多关于 KSF 的信息，其合伙人包括前路易斯安那州检察长，请访问 www.ksfcounsel.com。</p>
<p>Kahn Swick &amp; Foti, LLC</p>
<p>1100 Poydras St., Suite 960</p>
<p>新奥尔良，LA 70163</p>
<p>与我们联系：Facebook || Instagram || YouTube || TikTok || LinkedIn</p>
<p>来源 Kahn Swick &amp; Foti, LLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA3Jk5ld3NJdGVtSWQ9REE1ODUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDcxNzEyUFJfTkVXU19VU1BSX19fX19EQTU4NTM3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA3Jk5ld3NJdGVtSWQ9REE1ODUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDcxNzEyUFJfTkVXU19VU1BSX19fX19EQTU4NTM3"/></p>

BioCryst制药

ATXS

<p>Kahn Swick & Foti, LLC 正在调查 Astria Therapeutics, Inc. (ATXS) 拟议出售给 BioCryst Pharmaceuticals, Inc. (BCRX) 的事宜。股东将获得每股 Astria 8.55 美元现金和 0.59 股 BioCryst 股票。该公司旨在确定这一报价是否充分反映了公司的价值。感兴趣的各方可以联系 KSF 以获取有关其与此次出售相关的法律权利的更多信息</p>

<p>, /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (&#34;KSF&#34;) are investigating the proposed sale of Astria Therapeutics, Inc. (NasdaqGM: ATXS) to BioCryst Pharmaceuticals, Inc. (NasdaqGS: BCRX). Under the terms of the proposed transaction, shareholders of Astria will receive $8.55 in cash and 0.59 shares of BioCryst common stock for each share of Astria that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.</p>
<div class="lb-trans"><p>/PRNewswire/ -- 前路易斯安那州检察长查尔斯·C·福提（Charles C. Foti, Jr.）及其法律事务所 Kahn Swick &amp; Foti, LLC（&#34;KSF&#34;）正在调查 Astria Therapeutics, Inc.（纳斯达克代码：ATXS）拟出售给 BioCryst Pharmaceuticals, Inc.（纳斯达克代码：BCRX）的交易。根据拟议交易的条款，Astria 的股东将为每持有一股 Astria 股票获得 8.55 美元现金和 0.59 股 BioCryst 普通股。KSF 正在寻求确定这一对价及其形成过程是否合理，或者该对价是否低估了公司。</p>
</div><p>If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgm-atxs/ to learn more.</p>
<div class="lb-trans"><p>如果您认为该交易低估了公司，和/或如果您希望讨论您关于拟议出售的法律权利，您可以随时通过电子邮件或拨打 855-768-1857（免费电话）联系 KSF 管理合伙人路易斯·S·卡恩（Lewis S. Kahn）（[email protected]），而无需承担任何义务或费用，或访问 https://www.ksfcounsel.com/cases/nasdaqgm-atxs/以了解更多信息。</p>
</div><p>To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.</p>
<div class="lb-trans"><p>要了解更多关于 KSF 的信息，其合伙人包括前路易斯安那州检察长，请访问 www.ksfcounsel.com。</p>
</div><p>Kahn Swick &amp; Foti, LLC</p>
<div class="lb-trans"><p>Kahn Swick &amp; Foti, LLC</p>
</div><p>1100 Poydras St., Suite 960</p>
<div class="lb-trans"><p>1100 Poydras St., Suite 960</p>
</div><p>New Orleans, LA 70163</p>
<div class="lb-trans"><p>新奥尔良，LA 70163</p>
</div><p>CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn</p>
<div class="lb-trans"><p>与我们联系：Facebook || Instagram || YouTube || TikTok || LinkedIn</p>
</div><p>SOURCE Kahn Swick &amp; Foti, LLC</p>
<div class="lb-trans"><p>来源 Kahn Swick &amp; Foti, LLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA3Jk5ld3NJdGVtSWQ9REE1ODUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDcxNzEyUFJfTkVXU19VU1BSX19fX19EQTU4NTM3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DA58537&amp;Transmission_Id=202601071712PR_NEWS_USPR_____DA58537&amp;DateId=20260107"/></p>

17:12 ET
			
			
				Astria Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS

Astria Therapeutics 投资者警报：Kahn Swick & Foti, LLC 正在调查拟议出售 Astria Therapeutics, Inc.的价格和流程是否充分 - ATXS